PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

COMPANY UPDATE – 6 MONTHS 2018

2

Agenda

1 COMPANY OVERVIEW

BUSINESS OVERVIEW

FINANCIAL PERFORMANCE – 6M 2018

APPENDIX

2

3

4

COMPANY OVERVIEW

4

Preserving Indonesian heritage for more than 67 years andkeep maintaining the quality of the products

1951Founded by Mrs.Rakhmat Sulistio in1940 with the firstformula, Jamu TolakAngin. In 1951, thecompany SIDOMUNCUL wasestablished

1984Modern production facilitywas installed In order toaccommodate thegrowing market demand.The production facilitywas in LingkunganIndustri Kecil, Semarang.

2000The inauguration ofnew factory in an areaof 30ha, located inKlepu, with CPOB &CPOTB standard andalso equipped with ISOstandard facilities.

2013Conducted initial publicoffering with the issue priceof Rp580 per share, tickercode: SIDO.

2014Acquisition of PT BerlicoMulia Farma, expandingSido Muncul’s businessin the pharmaceuticalindustry

2017Commercializationthe new extractionfacilities of PTSemarang HerbalIndo Plant, withincrement ofextraction capacityand more efficient.

2018Finalization of thenew herbal liquidproduction facilities,more modern,integrated, withcapacity up to100mn sachets permonth

2004Marketing the first non-herbal product “KukuBima Ener-G!” originalflavor and has launchedvarious flavors to date.

5Gerry Mustika

Independent Director

Result of EGMS & AGMS – 2018

BOARD OF COMMISIONERS

Jonatha Sofjan HidajatPresident Commissioner

Sigit Hartojo Hadi SantosoCommissioner

Johan HidayatCommissioner

Ronnie BeharIndependent Commissioner

Eric MarnandusIndependent Commissioner

BOARD OF DIRECTORS

David HidayatPresident Director

Irwan HidayatDirector

LeonardIndependent Director

The EGMS conducted on January 31, 2018approved the appointment of Ronnie Beharand Eric Marnandus as IndependentCommissioners.

The AGMS conducted on May 30, 2018concluded:Declared cash dividend of Rp29 per share

or 80.85% of the Company’s 2017 net profitApproved the appointment of Jonatha

Sofjan Hidayat as President CommissionerApproved the appointment of David

Hidayat as President DirectorApproved the appointment of Leonard dan

Gerry Mustika as Independent Director

BUSINESS OVERVIEW

7

Product innovation, technology, also supported by strongdistribution network become the business driver of SidoMuncul

Vision :

To become a leading herbalmedicine, health food & drinks,

and herbal ingredientprocessing company which can

benefit the community andenvironment

1. PRODUCT QUALITYThe largest producer of

herbal medicine in Indonesiawith innovative products andstrong brand awareness in

the market.

2. PROCESSINGTECHNOLOGY

Production facilities withmodern and automation

technology

3. DISTRIBUTIONNETWORK

Strong distribution networkspread throughout Indonesiaand has penetrated overseas

market

4. SOCIALRESPONSIBILITY

Sustainable business for thebenefit of the company,

society, and environment

8

Product portfolio with featured products in each segments,has become TOP OF MIND in Indonesian consumers

Herbal Medicine PharmaceuticalFood & Beverages

1

9

New liquid herbal medicine production facility with moderntechnology and computerized

• Production capacityup to 100 mnsachets per monthfor all variants ofliquid herbalmedicine

• Modern, automatic,and more accurateto prevent mistakesin the productionprocess and humanerror

• Integratedproduction systemand more efficient

2

10

Strong distribution network spread throughout Indonesia

Sido Muncul PlantSemarang

Berlico PlantYogyakarta

Sub-distributors

SUMATERA: 24

JABODETABEK& JABAR: 16

KALIMANTAN: 9

JATENG: 12

SULAWESI: 13

JATIM: 14

EASTERN INDONESIA: 18

BALI & NT: 16

Muncul Mekar has 122 sub-distributors in general trade and cooperates with modernretail and pharmaceutical wholesalers, also online stores in Indonesia.

3

11

Developing potential of export market

• Established MunculNigeria Limited

• Product registrationprocess

• Established branchoffice

• Obtained productsregistrationapproval

• Initial production

Sido Muncul products have existed in several countries and to expand the export market,the company has been established branch office in Philippine (2017) and subsidiary inNigeria (2018)

3

12

Giving back to the community as part of the sustainability4

13

Received various awards related to branding, products,business, and also environment

FINANCIAL PERFORMANCE – 6M 2018

15

Financial performance – H1’18

Revenues increased by 5.4%, due to strong sales of Herbal & Supplements andPharmaceuticals in Q2’18

Operating profit increased by Rp 62bn or 20.4% compared to last year due to: Gross margin improvement came from termination of royalty payment since

Feb’18 and higher recovery rate from new facility of Semarang Herbal IndoPlant (SHI), producing higher yield of output to Herbal & Supplementsmaterials

Higher ASPs in Herbal & Supplements and Food & Beverages

SIDO booked double digit growth on bottom line with margin improvement in operationallevel

1,209

1,274

H1'17

H1'18

SALES

+5.4% YoY

534

636

+19.0% YoY

GROSS PROFIT

303

365

+20.4% YoY

OPERATING PROFIT

245

292

+19.1% YoY

NPAT

(Rp Billion – Unaudited)

16

Strong operational results in every business segments

Herbal Medicine Food & Beverages Pharmaceutical

788(65%)

847(66%)

374(31%)

375(30%)

47(4%)

52(4%)

Jun-17 Jun-18

%Growth

+7.4%

+0.4%

+10.9%1,209

1,274

SALES(%Proportional)

+5.4%

442(56%)

513(61%)

80(21%)

107(28%)

13(28%)

16(30%)

Jun-17 Jun-18

534(44%)

636(50%)+19.0%

Gross Profit(%Gross Profit Margin)

+16.2%

+34.0%

+21.4%

%Growth

(Rp Billion – Unaudited)

17

24 25 2629

86% 85% 82% 81%

2014 2015 2016 2017

421

197 176

345

163

2014 2015 2016 2017 Jun'18

Solid cash positions and high dividend payout ratio (>80%)

1,255

1,027 1,002903

1,059

2014 2015 2016 2017 Jun'18

(Rp Billion – 2014-2017 Audited & Jun’18 Unaudited)

CASH & CASH EQUIVALENTS

Payout Ratio

DIVIDEND PER SHARE

CAPEX

APPENDIX

19

SIDO structure

PT INDUSTRI JAMU DAN FARMASISIDO MUNCUL TBK

PT HOTEL CANDI BARU(81.0%)

*PUBLIC(19.0%)

MunculMekar SHI Berlico Muncul

Nigeria

99.99% 99.99% 99.99% 99.99%

*SIDO owns 0.8% from share buyback program

PT Muncul Mekar

The commencement ofoperation:

1987

Business activities:Trading

PT Semarang Herbal IndoPlant

The commencement ofoperation:

2009

Business activities:Herbal Extraction

PT Berlico Mulia Farma

The commencement ofoperation:

1993

Business activities:Pharmaceutical

Muncul Nigeria Limited

The commencement ofoperation:

2018

Business activities:Trading

20

Profit Or Loss – June 30, 2018

Rp Billion - Unaudited 30 June 2018 30 June 2017 ∆ %gr.SALES 1,274 1,209 65 5.4%COST OF GOODS SOLD (638) (675) 36 -5.4%GROSS PROFIT 636 534 101 19.0%%Margin 49.9% 44.2% 5.7%

Selling & Marketing Expenses (172) (156) (16) 10.5%General & Administrative Expenses (105) (81) (24) 29.7%Other Operational 7 6 1 18.4%OPERATING PROFIT 365 303 62 20.4%%Margin 28.7% 25.1% 3.6%

Finance Income 22 24 (2) -8.2%Finance Cost (0) (0) 0 -71.9%PROFIT BEFORE INCOME TAX EXPENSES 387 327 60 18.4%%Margin 30.4% 27.0% 3.3%

Income Tax Expense - Net (95) (82) (13) 16.3%PROFIT FOR THE YEAR 292 245 47 19.1%%Margin 22.9% 20.3% 2.6%

21

This presentation is made to provide information. No representation or warranty is made as to thefairness, accuracy, completeness or correctness of the information, opinions and conclusionscontained within this presentation. All information including business forward plans in thispresentation should not be considered as a recommendation in relation to holding purchasing orselling shares in any jurisdiction. No copy or use of this presentation should occur without thepermission of PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK.

Disclaimer

22

PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK

HEAD OFFICE:Gedung Menara Suara Merdeka, Lt. 16Jalan Pandanaran No. 30Semarang - Indonesia

BRANCH OFFICE:Grha Muncul MekarJl. Panjang Arteri Kelapa Dua, No. 27Kebon JerukJakarta Barat - Indonesia

EMAIL:investor.relation@sidomuncul.co.id